ft 19 apr 91 intern compani news pfizer advanc dollar 267m sale surg pfizer us pharmaceut compani yesterday report 17 per cent improv first quarter net incom 20 per cent rise sale strip discontinu oper 1990 result includ extraordinari item pfizer net incom first three month 1991 rose 6 per cent dollar 267 4m 79 cent share dollar 251 9m 75 cent year earlier earn per share restat reflect two one stock split januari 1990 quarter sale dekalb pfizer genet seed busi contribut dollar 39m pre tax incom sale quarter rose 14 per cent dollar 1 7bn dollar 1 48bn led growth pfizer health care oper quarter pfizer spent dollar 172 6m research develop 28 per cent first three month 1990 sale pfizer health care busi climb 22 per cent 1991 quarter sale pfizer anim health oper rose 11 per cent howev consum product sale rose modest 8 per cent underli sale specialti chemic miner improv 1 per cent although still worri litig pfizer shiley heart valv analyst bullish new product portfolio includ cardiovascular drug procardia xl diflucan aid relat fungal infect mr edmund pratt chairman chief execut said procardia xl diflucan contribut dollar 260m sale quarter norvasc cardura two new cardiovascular drug dollar 36m schere plough new jersey base pharmaceut health care product group lift first quarter earn dollar 173 2m 79 cent share dollar 150 4m 66 cent share year earlier write bernard simon new york sale rose dollar 949 3m dollar 865 1m despit sale last juli maybellin cosmet busi mr robert luciano chairman predict earn per share would climb 18 20 per cent 1991 compani attribut growth us pharmaceut sale solid demand anti cancer anti infect respiratori product